These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 24055075)

  • 1. Synthesis and pharmacological evaluation of novel N-aryl-3,4-dihydro-1'H-spiro[chromene-2,4'-piperidine]-1'-carboxamides as TRPM8 antagonists.
    Chaudhari SS; Kadam AB; Khairatkar-Joshi N; Mukhopadhyay I; Karnik PV; Raghuram A; Rao SS; Vaiyapuri TS; Wale DP; Bhosale VM; Gudi GS; Sangana RR; Thomas A
    Bioorg Med Chem; 2013 Nov; 21(21):6542-53. PubMed ID: 24055075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fused piperidines as a novel class of potent and orally available transient receptor potential melastatin type 8 (TRPM8) antagonists.
    Tamayo NA; Bo Y; Gore V; Ma V; Nishimura N; Tang P; Deng H; Klionsky L; Lehto SG; Wang W; Youngblood B; Chen J; Correll TL; Bartberger MD; Gavva NR; Norman MH
    J Med Chem; 2012 Feb; 55(4):1593-611. PubMed ID: 22329507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and optimization of benzimidazole-containing transient receptor potential melastatin 8 (TRPM8) antagonists.
    Parks DJ; Parsons WH; Colburn RW; Meegalla SK; Ballentine SK; Illig CR; Qin N; Liu Y; Hutchinson TL; Lubin ML; Stone DJ; Baker JF; Schneider CR; Ma J; Damiano BP; Flores CM; Player MR
    J Med Chem; 2011 Jan; 54(1):233-47. PubMed ID: 21128593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of vinylcycloalkyl-substituted benzimidazole TRPM8 antagonists effective in the treatment of cold allodynia.
    Calvo RR; Meegalla SK; Parks DJ; Parsons WH; Ballentine SK; Lubin ML; Schneider C; Colburn RW; Flores CM; Player MR
    Bioorg Med Chem Lett; 2012 Mar; 22(5):1903-7. PubMed ID: 22330635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of potency and pharmacokinetic properties of tetrahydroisoquinoline transient receptor potential melastatin 8 (TRPM8) antagonists.
    Horne DB; Tamayo NA; Bartberger MD; Bo Y; Clarine J; Davis CD; Gore VK; Kaller MR; Lehto SG; Ma VV; Nishimura N; Nguyen TT; Tang P; Wang W; Youngblood BD; Zhang M; Gavva NR; Monenschein H; Norman MH
    J Med Chem; 2014 Apr; 57(7):2989-3004. PubMed ID: 24597733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of novel SCD1 inhibitors: 5-alkyl-4,5-dihydro-3H-spiro[1,5-benzoxazepine-2,4'-piperidine] analogs.
    Uto Y; Ueno Y; Kiyotsuka Y; Miyazawa Y; Kurata H; Ogata T; Takagi T; Wakimoto S; Ohsumi J
    Eur J Med Chem; 2011 May; 46(5):1892-6. PubMed ID: 21356569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-type calcium channel blockers: spiro-piperidine azetidines and azetidinones-optimization, design and synthesis.
    Smith EM; Sorota S; Kim HM; McKittrick BA; Nechuta TL; Bennett C; Knutson C; Burnett DA; Kieselgof J; Tan Z; Rindgen D; Bridal T; Zhou X; Jia YP; Dong Z; Mullins D; Zhang X; Priestley T; Correll CC; Tulshian D; Czarniecki M; Greenlee WJ
    Bioorg Med Chem Lett; 2010 Aug; 20(15):4602-6. PubMed ID: 20580233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arylglycine derivatives as potent transient receptor potential melastatin 8 (TRPM8) antagonists.
    Zhu B; Xia M; Xu X; Ludovici DW; Tennakoon M; Youngman MA; Matthews JM; Dax SL; Colburn RW; Qin N; Hutchinson TL; Lubin ML; Brandt MR; Stone DJ; Flores CM; Macielag MJ
    Bioorg Med Chem Lett; 2013 Apr; 23(7):2234-7. PubMed ID: 23411075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The design and synthesis of novel, phosphonate-containing transient receptor potential melastatin 8 (TRPM8) antagonists.
    Matthews JM; Qin N; Colburn RW; Dax SL; Hawkins M; McNally JJ; Reany L; Youngman MA; Baker J; Hutchinson T; Liu Y; Lubin ML; Neeper M; Brandt MR; Stone DJ; Flores CM
    Bioorg Med Chem Lett; 2012 Apr; 22(8):2922-6. PubMed ID: 22421018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and optimization of novel (3S,5R)-5-(2,2-dimethyl-5-oxo-4-phenylpiperazin-1-yl)piperidine-3-carboxamides as orally active renin inhibitors.
    Mori Y; Ogawa Y; Mochizuki A; Nakamura Y; Fujimoto T; Sugita C; Miyazaki S; Tamaki K; Nagayama T; Nagai Y; Inoue S; Chiba K; Nishi T
    Bioorg Med Chem; 2013 Sep; 21(18):5907-22. PubMed ID: 23886807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3-Phenyl-5-isothiazole carboxamides with potent mGluR1 antagonist activity.
    Fisher MJ; Backer RT; Barth VN; Garbison KE; Gruber JM; Heinz BA; Iyengar S; Hollinshead SP; Kingston A; Kuklish SL; Li L; Nisenbaum ES; Peters SC; Phebus L; Simmons RM; van der Aar E
    Bioorg Med Chem Lett; 2012 Apr; 22(7):2514-7. PubMed ID: 22386665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery and biological evaluation of 5-aryl-2-furfuramides, potent and selective blockers of the Nav1.8 sodium channel with efficacy in models of neuropathic and inflammatory pain.
    Kort ME; Drizin I; Gregg RJ; Scanio MJ; Shi L; Gross MF; Atkinson RN; Johnson MS; Pacofsky GJ; Thomas JB; Carroll WA; Krambis MJ; Liu D; Shieh CC; Zhang X; Hernandez G; Mikusa JP; Zhong C; Joshi S; Honore P; Roeloffs R; Marsh KC; Murray BP; Liu J; Werness S; Faltynek CR; Krafte DS; Jarvis MF; Chapman ML; Marron BE
    J Med Chem; 2008 Feb; 51(3):407-16. PubMed ID: 18176998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3-Oxoisoindoline-1-carboxamides: potent, state-dependent blockers of voltage-gated sodium channel Na(V)1.7 with efficacy in rat pain models.
    Macsari I; Besidski Y; Csjernyik G; Nilsson LI; Sandberg L; Yngve U; Ahlin K; Bueters T; Eriksson AB; Lund PE; Venyike E; Oerther S; Hygge Blakeman K; Luo L; Arvidsson PI
    J Med Chem; 2012 Aug; 55(15):6866-80. PubMed ID: 22770500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 4-Amino-2-alkyl-butyramides as small molecule CCR2 antagonists with favorable pharmacokinetic properties.
    Butora G; Morriello GJ; Kothandaraman S; Guiadeen D; Pasternak A; Parsons WH; MacCoss M; Vicario PP; Cascieri MA; Yang L
    Bioorg Med Chem Lett; 2006 Sep; 16(18):4715-22. PubMed ID: 16870431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of potent, selective, and orally bioavailable 3H-spiro[isobenzofuran-1,4'-piperidine] based melanocortin subtype-4 receptor agonists.
    Guo L; Ye Z; Liu J; He S; Bakshi RK; Sebhat IK; Dobbelaar PH; Hong Q; Jian T; Dellureficio JP; Tsou NN; Ball RG; Weinberg DH; MacNeil T; Tang R; Tamvakopoulos C; Peng Q; Chen HY; Chen AS; Martin WJ; MacIntyre DE; Strack AM; Fong TM; Wyvratt MJ; Nargund RP
    Bioorg Med Chem Lett; 2010 Aug; 20(16):4895-900. PubMed ID: 20621473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potent nonpeptide antagonists of the bradykinin B1 receptor: structure-activity relationship studies with novel diaminochroman carboxamides.
    Biswas K; Li A; Chen JJ; D'Amico DC; Fotsch C; Han N; Human J; Liu Q; Norman MH; Riahi B; Yuan C; Suzuki H; Mareska DA; Zhan J; Clarke DE; Toro A; Groneberg RD; Burgess LE; Lester-Zeiner D; Biddlecome G; Manning BH; Arik L; Dong H; Huang M; Kamassah A; Loeloff R; Sun H; Hsieh FY; Kumar G; Ng GY; Hungate RW; Askew BC; Johnson E
    J Med Chem; 2007 May; 50(9):2200-12. PubMed ID: 17408249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
    Tewes B; Frehland B; Schepmann D; Schmidtke KU; Winckler T; Wünsch B
    Bioorg Med Chem; 2010 Nov; 18(22):8005-15. PubMed ID: 20965739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of a potent, selective, and orally active human epidermal growth factor receptor-2 sheddase inhibitor for the treatment of cancer.
    Yao W; Zhuo J; Burns DM; Xu M; Zhang C; Li YL; Qian DQ; He C; Weng L; Shi E; Lin Q; Agrios C; Burn TC; Caulder E; Covington MB; Fridman JS; Friedman S; Katiyar K; Hollis G; Li Y; Liu C; Liu X; Marando CA; Newton R; Pan M; Scherle P; Taylor N; Vaddi K; Wasserman ZR; Wynn R; Yeleswaram S; Jalluri R; Bower M; Zhou BB; Metcalf B
    J Med Chem; 2007 Feb; 50(4):603-6. PubMed ID: 17256836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spiroindane based amides as potent and selective MC4R agonists for the treatment of obesity.
    He S; Ye Z; Dobbelaar PH; Sebhat IK; Guo L; Liu J; Jian T; Lai Y; Franklin CL; Bakshi RK; Dellureficio JP; Hong Q; Weinberg DH; Macneil T; Tang R; Strack AM; Tamvakopoulos C; Peng Q; Miller RR; Stearns RA; Chen HY; Chen AS; Fong TM; Wyvratt MJ; Nargund RP
    Bioorg Med Chem Lett; 2010 Aug; 20(15):4399-405. PubMed ID: 20598882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antinociceptive effect of two novel transient receptor potential melastatin 8 antagonists in acute and chronic pain models in rat.
    De Caro C; Russo R; Avagliano C; Cristiano C; Calignano A; Aramini A; Bianchini G; Allegretti M; Brandolini L
    Br J Pharmacol; 2018 May; 175(10):1691-1706. PubMed ID: 29485712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.